Data as of 4:00pm ET
| -0.24 / -2.26%|
The 6 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 21.50, with a high estimate of 24.00 and a low estimate of 20.00. The median estimate represents a +107.13% increase from the last price of 10.38.
The current consensus among 8 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.